| scholarly article | Q13442814 |
| P50 | author | Niels Høiby | Q12328808 |
| Henrik Enghusen Poulsen | Q33310622 | ||
| Oana Ciofu | Q40705960 | ||
| Lasse Engbo Christiansen | Q42754296 | ||
| P2093 | author name string | N Kirkby | |
| L F Mandsberg | |||
| P2860 | cites work | Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 |
| Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate | Q24564458 | ||
| State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? | Q24802489 | ||
| Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1 | Q28190916 | ||
| Evolution of mutation rates in bacteria | Q28238561 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Characterization of the GO system of Pseudomonas aeruginosa | Q28492940 | ||
| Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa | Q28493072 | ||
| Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa | Q29615291 | ||
| The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) | Q29619959 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| New antimicrobials in the management of cystic fibrosis | Q34508869 | ||
| Antimutator role of the DNA glycosylase mutY gene in Helicobacter pylori | Q35075343 | ||
| The mutant selection window and antimicrobial resistance | Q35153856 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Role of a MutY DNA glycosylase in combating oxidative DNA damage in Helicobacter pylori | Q35691709 | ||
| Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy | Q35754096 | ||
| Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. | Q35879111 | ||
| Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies | Q35908307 | ||
| Survival strategies of infectious biofilms | Q36003660 | ||
| Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation | Q36295397 | ||
| Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates | Q37007127 | ||
| Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA | Q37132610 | ||
| Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria | Q37608709 | ||
| Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli | Q38665569 | ||
| Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q39473195 | ||
| Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. | Q39609617 | ||
| Different spectra of stationary-phase mutations in early-arising versus late-arising mutants of Pseudomonas putida: involvement of the DNA repair enzyme MutY and the stationary-phase sigma factor RpoS. | Q39680847 | ||
| Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa | Q39781815 | ||
| Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion | Q40968218 | ||
| Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| Pulmonary oxidative stress response in young children with cystic fibrosis | Q42152011 | ||
| Oxidative DNA damage defense systems in avoidance of stationary-phase mutagenesis in Pseudomonas putida | Q42412527 | ||
| Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase | Q42496962 | ||
| Pseudomonas aeruginosa-induced lung injury: role of oxidative stress | Q43848320 | ||
| Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. | Q44012036 | ||
| Interactions among the Escherichia coli mutT, mutM, and mutY damage prevention pathways | Q44280600 | ||
| Lipid peroxidation of lung surfactant due to reactive oxygen species released from phagocytes stimulated by bacteria from children with cystic fibrosis | Q44689347 | ||
| Characterization of starvation-induced dispersion in Pseudomonas putida biofilms | Q46489224 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. | Q47946251 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa | Q48073553 | ||
| Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli | Q48248666 | ||
| Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli | Q49201462 | ||
| Effects of overexpression and antisense RNA expression of Orf17, a MutT-type enzyme. | Q54464045 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Suppression of spontaneous and hydrogen peroxide-induced mutations by a MutT-type nucleotide pool sanitization enzyme, the Escherichia coli Orf135 protein | Q57751251 | ||
| Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis | Q61477562 | ||
| Evidence for increased oxidative damage in patients with cystic fibrosis | Q72397235 | ||
| Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment | Q73556642 | ||
| Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
| Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis | Q80385327 | ||
| Oxidative changes of bronchoalveolar proteins in cystic fibrosis | Q82554110 | ||
| Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates | Q82856564 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| antibiotic resistance | Q380775 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2483-2491 | |
| P577 | publication date | 2009-03-30 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system | |
| P478 | volume | 53 |
| Q33576726 | A MATE-family efflux pump rescues the Escherichia coli 8-oxoguanine-repair-deficient mutator phenotype and protects against H(2)O(2) killing |
| Q35230652 | Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q30403958 | Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. |
| Q90380584 | Contribution of GO System Glycosylases to Mutation Prevention in Caulobacter crescentus |
| Q41833848 | Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators |
| Q24609407 | Efflux-mediated drug resistance in bacteria: an update |
| Q37896674 | Emergence and spread of antibiotic resistance following exposure to antibiotics |
| Q38211644 | Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings |
| Q36559344 | Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptation |
| Q28359832 | Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model |
| Q38962871 | Involvement of stress-related genes polB and PA14_46880 in biofilm formation of Pseudomonas aeruginosa |
| Q51173006 | Microbial ecology and adaptation in cystic fibrosis airways. |
| Q34117477 | Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections |
| Q37888731 | New horizons for cutaneous microbiology: the role of biofilms in dermatological disease |
| Q38006032 | Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections |
| Q38645992 | Phenotypic and genetic heterogeneity within biofilms with particular emphasis on persistence and antimicrobial tolerance. |
| Q46597577 | Poor antioxidant status exacerbates oxidative stress and inflammatory response to Pseudomonas aeruginosa lung infection in guinea pigs. |
| Q42734622 | Preparation and physicochemical characterization of amoxicillin beta-cyclodextrin complexes |
| Q40058358 | Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection. |
| Q38268531 | Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. |
| Q28299966 | Pseudomonas aeruginosa biofilms in cystic fibrosis |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q33559774 | Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients |
| Q37464130 | Reactive oxygen species drive evolution of pro-biofilm variants in pathogens by modulating cyclic-di-GMP levels |
| Q42572942 | Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa |
| Q40293607 | Surface charge modification decreases Pseudomonas aeruginosa adherence in vitro and bacterial persistence in an in vivo implant model |
| Q35482558 | The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria |
| Q28492495 | The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa |
| Q38300820 | The problems of antibiotic resistance in cystic fibrosis and solutions |
| Q35885995 | The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa |
| Q36469527 | The role of 2,4-dihydroxyquinoline (DHQ) in Pseudomonas aeruginosa pathogenicity |
Search more.